MSB 0.92% $1.08 mesoblast limited

CDC issues new Opioid guidlines, page-7

  1. 590 Posts.
    lightbulb Created with Sketch. 296
    For those interested in another opioid crisis play MVP's green whistle is a good example of non opioid analgesic selling in so many countries around the world except usa where the fda put it on clinical hold and so now they are redesigning the phase 3. usa approval might be a few years away but could also be right place right time with these new guidelines. non holder just thought it was relevant to this topic.
    reverse commercialisation strategy to us. usa last, and all the approvals and evidence in other countries means nothing to the fda. some holders here have suggested the same strategy. can't say i agree.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.08
Change
-0.010(0.92%)
Mkt cap ! $1.233B
Open High Low Value Volume
$1.10 $1.11 $1.05 $5.002M 4.632M

Buyers (Bids)

No. Vol. Price($)
2 5697 $1.08
 

Sellers (Offers)

Price($) Vol. No.
$1.09 1000 1
View Market Depth
Last trade - 16.10pm 14/06/2024 (20 minute delay) ?
Last
$1.09
  Change
-0.010 ( 0.10 %)
Open High Low Volume
$1.09 $1.11 $1.06 1181223
Last updated 15.59pm 14/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.